Journal Information
Vol. 162. Issue 7.
Pages 358-359 (April 2024)
Vol. 162. Issue 7.
Pages 358-359 (April 2024)
Letter to the Editor
Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
Miositis y miocarditis tras terapia combinada de tremelimumab y durvalumab en el carcinoma hepatocelular
Thais Lizondo López
, Iria Carro Méndez, Esther Carcelero San Martín
Corresponding author
Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail